Memantine (Axura)
Substance developed by the Merz research organization used to treat dementia and Alzheimer's Disease.
NMDA receptor antagonist - Wikipedia, the free encyclopedia
(Redirected from NMDA antagonist) Jump to: navigation, search ... Memantine: moderate affinity, voltage-dependent uncompetitive antagonist.[37] ...
NMDA - Wikipedia, the free encyclopedia
Examples of antagonists of the NMDA receptor are APV, Amantadine, ... riluzole, memantine, and kynurenic acid, the only known endogenous antagonist. ...
Memantine, L5
As an NMDA antagonist, memantine prevents the neurotransmitter glutamate from ... Memantine differs from other NMDA non-competitive antagonists in that it allows ...
Failures and Successes of NMDA Receptor Antagonists: Molecular Basis ...
THE QUEST FOR NMDA RECEPTOR ANTAGONISTS. EXCITOTOXICITY. MEMANTINE. NITROMEMANTINES. SUMMARY ... NMDA antagonist, open channel blocker, memantine. Top ...
memantine.com - Preclinical Data of Memantine
Memantine is an NMDA receptor antagonist that has been recently approved in EU ... first clinically available NMDA receptor antagonist: effective and safe! ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... Namenda® (memantine hydrochloride) is an orally active NMDA receptor antagonist. ...
Clinically available NMDA receptor antagonists memantine and ...
NMDA antagonist · Memantine · Dextromethorphan · MRZ 2/579 · Analgesia ... Popik P, Skolnick P (1996) The NMDA antagonist memantine ...
Memantine - Pubdrug
Memantine is the only NMDA antagonist on the market to date and is approved for ... Memantine is a non-competitive antagonist which blocks the N-methyl ...
Memantine: Information from Answers.com
Memantine Memantine is a new drug for treating Alzheimer's disease, mental ... Memantine: a NMDA receptor antagonist that improves memory by restoration of ...
|
The NMDA antagonist memantine impairs classical ey...[Neurosci Lett. 1997] - PubMed Result
Institute of Medical Psychology and Behavioral Neurobiology, University of Tubingen, Germany. markus.schugens@uni-tuebingen.deThe present study investigated the effects of a single oral dose (30 mg) of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine on memory and learning in human subjects. Sixteen male healthy volunteers participated in a double blind placebo controlled study. There were no significant effects of memantine on mood, attention or immediate and delayed verbal and visuospatial memory. Memantine did, however, delay the acquisition of classical eyeblink conditioning and reduced the overall frequency of conditioned responses without affecting reflex or spontaneous eyeblinks.